GENEVA, March 30 -- MYLLIA BIOTECHNOLOGY GMBH (Am Kanal 271110 Vienna) filed a patent application (PCT/EP2025/076501) for "GENE PERTURBATION IN HUMAN MONOCYTE-DERIVED MACROPHAGES" on Sep 17, 2025. With publication no. WO/2026/062037, the details related to the patent application was published on Mar 26, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): PAWAR, Sumit (Hornesgasse 22/91030 Vienna), BADERTSCHER, Lukas (Grosse Sperlgasse 32-341020 Vienna)
Abstract: A method of engineering human monocyte-derived macrophage (MDMs) by a genomic perturbation of a gene in said MDMs using lentiviral del...